Literature DB >> 14722454

Breast-feeding and Transmission of HIV-1.

Grace John-Stewart1, Dorothy Mbori-Ngacha, Rene Ekpini, Edward N Janoff, John Nkengasong, Jennifer S Read, Phillippe Van de Perre, Marie-Louise Newell.   

Abstract

Breast-feeding substantially increases the risk of HIV-1 transmission from mother to child, and although peripartum antiretroviral therapy prophylaxis significantly decreases the risk of mother-to-child transmission around the time of delivery, this approach does not affect breast-feeding transmission. Increased maternal RNA viral load in plasma and breast milk is strongly associated with increased risk of transmission through breast-feeding, as is breast health, and it has been suggested that exclusive breast-feeding could be associated with lower rates of breast-feeding transmission than mixed feeding of both breast- and other milk or feeds. Transmission through breast-feeding can take place at any point during lactation, and the cumulative probability of acquisition of infection increases with duration of breast-feeding. HIV-1 has been detected in breast milk in cell-free and cellular compartments; infant gut mucosal surfaces are the most likely site at which transmission occurs. Innate and acquired immune factors may act most effectively in combination to prevent primary HIV-1 infection by breast milk.

Entities:  

Mesh:

Year:  2004        PMID: 14722454      PMCID: PMC3382106          DOI: 10.1097/00126334-200402010-00015

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  46 in total

1.  Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group.

Authors:  N Shaffer; R Chuachoowong; P A Mock; C Bhadrakom; W Siriwasin; N L Young; T Chotpitayasunondh; S Chearskul; A Roongpisuthipong; P Chinayon; J Karon; T D Mastro; R J Simonds
Journal:  Lancet       Date:  1999-03-06       Impact factor: 79.321

Review 2.  Infant feeding and HIV-1 infection.

Authors:  A Nicoll; M L Newell; C Peckham; C Luo; F Savage
Journal:  AIDS       Date:  2000       Impact factor: 4.177

3.  Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine.

Authors:  E P Coakley; J M Gillis; S M Hammer
Journal:  AIDS       Date:  2000-01-28       Impact factor: 4.177

4.  6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant.

Authors:  F Dabis; P Msellati; N Meda; C Welffens-Ekra; B You; O Manigart; V Leroy; A Simonon; M Cartoux; P Combe; A Ouangré; R Ramon; O Ky-Zerbo; C Montcho; R Salamon; C Rouzioux; P Van de Perre; L Mandelbrot
Journal:  Lancet       Date:  1999-03-06       Impact factor: 79.321

5.  Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial.

Authors:  S Z Wiktor; E Ekpini; J M Karon; J Nkengasong; C Maurice; S T Severin; T H Roels; M K Kouassi; E M Lackritz; I M Coulibaly; A E Greenberg
Journal:  Lancet       Date:  1999-03-06       Impact factor: 79.321

6.  Epithelial uptake and transport of cell-free human immunodeficiency virus type 1 and gp120-coated microparticles.

Authors:  A Kage; E Shoolian; K Rokos; M Ozel; R Nuck; W Reutter; E Köttgen; G Pauli
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

Authors:  D R Bangsberg; F M Hecht; E D Charlebois; A R Zolopa; M Holodniy; L Sheiner; J D Bamberger; M A Chesney; A Moss
Journal:  AIDS       Date:  2000-03-10       Impact factor: 4.177

8.  Cell-free human immunodeficiency virus type 1 in breast milk.

Authors:  P Lewis; R Nduati; J K Kreiss; G C John; B A Richardson; D Mbori-Ngacha; J Ndinya-Achola; J Overbaugh
Journal:  J Infect Dis       Date:  1998-01       Impact factor: 5.226

9.  Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections.

Authors:  G C John; R W Nduati; D A Mbori-Ngacha; B A Richardson; D Panteleeff; A Mwatha; J Overbaugh; J Bwayo; J O Ndinya-Achola; J K Kreiss
Journal:  J Infect Dis       Date:  2000-12-15       Impact factor: 5.226

10.  HIV transmission through breastfeeding: a study in Malawi.

Authors:  P G Miotti; T E Taha; N I Kumwenda; R Broadhead; L A Mtimavalye; L Van der Hoeven; J D Chiphangwi; G Liomba; R J Biggar
Journal:  JAMA       Date:  1999-08-25       Impact factor: 56.272

View more
  37 in total

1.  Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization.

Authors:  Barb Lohman-Payne; Jennifer Slyker; Sarah L Rowland-Jones
Journal:  Clin Perinatol       Date:  2010-12       Impact factor: 3.430

2.  Pharmacokinetics of tenofovir in breast milk of lactating rhesus macaques.

Authors:  Koen K A Van Rompay; Marta Hamilton; Brian Kearney; Norbert Bischofberger
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

3.  Pediatric HIV type 1 vaccine trial acceptability among mothers in Kenya.

Authors:  Carey Farquhar; Grace C John-Stewart; Francis N John; Marjory N Kabura; James N Kiarie
Journal:  AIDS Res Hum Retroviruses       Date:  2006-06       Impact factor: 2.205

4.  A summary of the workshop on passive immunization using monoclonal antibodies for HIV/AIDS, held at the National Institute of Allergy and Infectious Diseases, Bethesda, 10 March 2006.

Authors:  Geetha P Bansal
Journal:  Biologicals       Date:  2007-09-21       Impact factor: 1.856

5.  Quantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1: a combined pharmacokinetic, pharmacodynamic, and viral dynamic analysis to predict clinical outcomes.

Authors:  M Frank; M von Kleist; A Kunz; G Harms; C Schütte; C Kloft
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

Review 6.  The role of HIV replicative fitness in perinatal transmission of HIV.

Authors:  Xue-Qing Chen; Chang Liu; Xiao-Hong Kong
Journal:  Virol Sin       Date:  2011-06-12       Impact factor: 4.327

7.  Mother-to-child transmission of HIV: a global perspective.

Authors:  Katherine Luzuriaga
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

8.  Complementary feeding adequacy in relation to nutritional status among early weaned breastfed children who are born to HIV-infected mothers: ANRS 1201/1202 Ditrame Plus, Abidjan, Cote d'Ivoire.

Authors:  Renaud Becquet; Valériane Leroy; Didier K Ekouevi; Ida Viho; Katia Castetbon; Patricia Fassinou; François Dabis; Marguerite Timite-Konan
Journal:  Pediatrics       Date:  2006-04       Impact factor: 7.124

9.  Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine.

Authors:  Michael H Chung; James N Kiarie; Barbra A Richardson; Dara A Lehman; Julie Overbaugh; Grace C John-Stewart
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

10.  The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.

Authors:  Caitlin J McCabe; Sue J Goldie; David N Fisman
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.